PCM
Prentice Capital Management’s Immunome IMNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-112,131
| Closed | -$1.2M | – | 24 |
|
|
2023
Q4 | $1.2M | Hold |
112,131
| – | – | 2.79% | 12 |
|
|
2023
Q3 | $936K | Hold |
112,131
| – | – | 2.88% | 11 |
|
|
2023
Q2 | $887K | Sell |
112,131
-319,773
| -74% | -$2.53M | 2.83% | 16 |
|
|
2023
Q1 | $2.16M | Sell |
431,904
-66,241
| -13% | -$331K | 4.62% | 8 |
|
|
2022
Q4 | $1.1M | Sell |
498,145
-293,676
| -37% | -$649K | 1.2% | 21 |
|
|
2022
Q3 | $3.52M | Hold |
791,821
| – | – | 2.61% | 13 |
|
|
2022
Q2 | $2.54M | Sell |
791,821
-500
| -0.1% | -$1.61K | 1.04% | 18 |
|
|
2022
Q1 | $4.5M | Sell |
792,321
-14,200
| -2% | -$80.6K | 1.07% | 21 |
|
|
2021
Q4 | $10.5M | Buy |
806,521
+289,341
| +56% | +$3.75M | 2.26% | 16 |
|
|
2021
Q3 | $12.6M | Hold |
517,180
| – | – | 3.18% | 13 |
|
|
2021
Q2 | $8.95M | Buy |
517,180
+185,185
| +56% | +$3.2M | 2.14% | 19 |
|
|
2021
Q1 | $11.2M | Sell |
331,995
-84,672
| -20% | -$2.87M | 3.49% | 11 |
|
|
2020
Q4 | $4.03M | Buy |
+416,667
| New | +$4.03M | 1.09% | 16 |
|